Short answer: An EU buyer cannot decide whether a cosmetic light device falls under Medical Devices Regulation (MDR) Annex XVI just by seeing the words “laser,” “IPL,” “LED” or “radiofrequency” on a sales sheet. Medical Device Coordination Group (MDCG) guidance says the intended purpose and characteristics of the equipment matter. Group 5 covers high-intensity electromagnetic-radiation equipment intended for use on the human body for specified skin treatments, including certain laser and intense pulsed light (IPL) applications without an intended medical purpose. The exact regulatory route needs a product-specific assessment.
Start with the marketed purpose
The MDCG’s 2023-5 guidance explains that Annex XVI lists products without an intended medical purpose that are nevertheless covered by the MDR framework and common specifications. For Group 5, it discusses equipment for skin resurfacing, tattoo or hair removal and other skin treatment. The examples include skin rejuvenation and removal of permanent makeup. A treatment indication on packaging, a website or operator instructions is therefore an important part of the assessment. If a device is presented for a medical condition, the analysis may take a different path; “cosmetic” in a brochure cannot be used to erase a therapeutic claim elsewhere.
The guidance also cautions against treating every optical or energy-emitting appliance as the same product. It says the high-intensity concept depends on whether radiation can cause the tissue effect needed to achieve the intended purpose; the examples of infrared, visible and ultraviolet light alone do not define the threshold. It notes radiofrequency may be another type of electromagnetic radiation for this purpose. Conversely, the document gives examples outside the common specifications, including infrared equipment used to warm the body or part of it, and sunbeds. These distinctions are useful when a distributor receives one generic “CE file” for devices with very different functions.
Ask for an intended-purpose map
For every proposed model, request a short list of the uses the manufacturer actually claims, the energy source and delivery method, the contact area, user type, instructions, contraindications and accessory variants. Compare that list with the quoted machine and its public marketing. If the product has multiple uses, ask how classification and conformity assessment address them all. The MDCG guidance explains that dual-purpose products need consideration of both medical and non-medical purposes, and where more than one classification rule applies, the stricter resulting classification may govern.
Do not treat a classification example as an authorization for a particular result. The MDCG’s examples are meant to support interpretation of regulatory scope, not to prove clinical effectiveness or safety of a named model. Buyers should request the relevant declaration, technical documentation and instructions and have an EU regulatory specialist review ambiguous configurations or claims before distribution.
Limits and date
MDCG 2023-5 is guidance published in December 2023, not a new October 2026 rule or a determination about any TUOKE equipment. The underlying EU legislation and national enforcement context must be checked for the exact product and sale date. This article does not claim that TUOKE has a Group 5 device or an MDR certificate, and it is not legal advice.
For further buyer-oriented context, use the optical aesthetic equipment insights archive.
Source
- European Commission, MDCG 2023-5 guidance on Annex XVI products, December 2023; reviewed 12 October 2026.